Search results for " pharmaceutical"

Article ADC Development Robust Despite Lackluster Performance
Seattle Genetics is developing brentuximab vedotin in collaboration with Takeda Pharmaceutical, under which Seattle Genetics has the commercialization rights in the US and Canada while Takeda has comm…

Article Patenting Prospects for Cell-Based Therapies
Conclusion Cell-based therapies represent in many ways the cutting edge of medicine, promising to provide treatments for diseases that cannot be treated (at least adequately) using conventional ph…

Article From Darwin to Recombinant Fc Multimers
   Carlos Bosques from Momenta Pharmaceuticals had a presentation titled IVIg-Inspired Drugs for Improved Therapy in Autoimmune Diseases in the Application session. IVIg has been a treatment optio…

Article Managing Residual Impurities During Downstream Processing
…ufacture of biologic drugs, according to Ashleigh Wake, director of biological services for Intertek Pharmaceutical Services. The scientific and technical fields are evolving, agrees Bérangère Tis…

Article Witnessing Major Growth in Next-Generation Antibodies
Both large and small pharmaceutical and biotech companies are pursuing these newer therapies. A few have already been approved, and many more are in preclinical and clinical development. There are num…

Article Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
The problem of copying biologics Biologic drugs have revolutionized the pharmaceutical industry by attacking disease using the mechanisms of the cell and immune system. These therapies are fragile…

Article Advancing Single-Use Technology Through Collaboration
“In the traditional pharmaceutical business, you spend a lot of time washing and sterilizing items to avoid the cross-contamination concerns. In single use, that water use is reduced to almost nothing…

Article Lessons Learned Accelerate Vaccine Development
Teamwork and multi-tasking at Janssen Janssen Vaccines, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, received the 2016 Facility of the Year Award for Project Execution for it…

Article Innovative Therapies Require Modern Manufacturing Systems
Jenkins voiced concern, however, about the continued emergence of new therapies, noting the need for FDA to assist pharmaceutical manufacturers seeking to accelerate the production timeframes for more…

Article Risk Assessment and Mitigation in Biopharmaceutical Manufacturing
In general, a biopharmaceutical manufacturer faces similar business continuity risks as those of traditional pharmaceutical manufacturers. BioPharm: Does the use of single-use systems (SUS) and/or…

Previous PageNext Page